SAN ANTONIO, Aug. 24, 2018 /PRNewswire/ -- Louis Fabre MD PhD, is recognized by ContinentalWho's Who as a Top Psychiatrist for his work in developing most of the psychiatric drugs from 1970 to 2000.
Early in his career, Dr. Fabre was told to be an expert; you have to see patients, go to conferences, give lectures,
Dr. Fabre received his PhD from Case Western Reserve University in 1966 and his MD from Baylor College in 1969. Board Certified by the American Board of Psychiatry and Neurology, Dr. Fabre completed his Psychiatric Residency at Baylor Affiliated Hospitals.
From 1974 to 2005, Dr. Fabre was the Owner and President of Research Testing Inc., and from 1992 he has been Chairman of the Board for Fabre Kramer Pharmaceuticals Inc. The author of several patents, Dr. Fabre has published almost 200 scientific papers. A recent paper on Sexual Dysfunction in Women was judged to be in the top 2% of all papers written. He has given over 1000 speeches. He has taught at all university levels.
Currently, Dr. Fabre is a practicing Psychiatrist at Alamo Mental Health Group in San Antonio. He sees about 150 patients a week. He is working on new concepts in the diagnosis and treatment of bipolar disorder and major depression.
A seasoned pilot with over 6000 hours as 'pilot in command' over 1000 in jets, Dr. Fabre has ran over 19 marathons including the Boston Marathon. Dr. Fabre has 8 children. His wife, Lean, will deliver his ninth in March 2018.
Because of his contributions to the armamentarium against psychiatric illness, he has been referred to as the Father of Modern Psychopharmacology.
Contact: Katherine Green, 516-825-5634, firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/louis-fabre-md-phd-is-recognized-by-continental-whos-who-300702208.html
SOURCE Continental Who's Who
Subscribe to our Free Newsletters!
Take the quiz on Rabies and test your knowledge about this infection that can affect the brain ...
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...View All